Congruently, SPP1 was shown to recruit GAMs to mouse gliomas via αvβ5 integrin, and systemic administration of osteopontin-eliminating aptamers increased the median survival time of tumor-bearing animals by 68% [22]. This evidence concerns the gene SPP1 and glioma.